Found 450 matching trials
A Combination Study of CAR-T Therapy in r/r B-NHL PHASE2 In registry studies of CAR-T products that have been marketed globally, pat...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Study of IFN-α Combined With CAR-T Cell Therapy in Relapsed and Refractory Acute Lymphoblastic Leukemia(R/R-ALL) PHASE2 The purpose of this study is to evaluate the safety and efficacy of IFN-α c...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Clinical Study of Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma PHASE1 This is a phase I clinical study to evaluate the safety and efficacy of CAR...
Show More Location
Shandong Second Provincial General Hospital
Learn More & Join Trial
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases PHASE1 The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Show More Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Learn More & Join Trial
Treatment of Chemotherapy Refractory Multiple Myeloma by CART-138 PHASE1 RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells N/A The purpose of this study is to assess long-term side effects from subjects...
Show More Status
Active Not Recruiting
Location
Blood and Marrow Transplant Program
Learn More & Join Trial
Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy EARLY_PHASE1 This is a single arm, open-label, early phase Ⅰ study, to determine the saf...
Show More Location
Hunan Provincial People's Hospital
Learn More & Join Trial
A Clinical Study Investigating the Therapeutic Effects and Safety of an Investigational Cell Therapy Given With and Without an Additional Investigational Product in Males With Testicular Cancer or a Form of Cancer That Developed From Sperm PHASE2 This study is designed to evaluate the safety, efficacy, cellular kinetics,...
Show More Location
Multiple Locations
Learn More & Join Trial
CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients PHASE1 The purpose of this study is to evaluate the safety and effectiveness of CA...
Show More Location
Multiple Locations
Learn More & Join Trial